CXCL9:

Evangelos J Giamarellos-Bourboulis1, Massimo Antonelli2, Frank Bloos3

  • 14(th) Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece; Hellenic Institute for the Study of Sepsis, Athens, Greece.

EBioMedicine
|October 24, 2024
PubMed
概括

干扰素 (IFNγ) 驱动的败血症 (IDS) 是一种新发现的败血症内型. 这种情况独立地与败血症患者的死亡风险更高有关.